Salud

$0.14 EPS Expected for Healthequity (HQY); Autoliv (ALV) SI Decreased By 1.49%

$0.14 EPS Expected for Healthequity (HQY); Autoliv (ALV) SI Decreased By 1.49%

Oppenheimer Asset Management Inc. acquired a new stake in shares of HealthEquity, Inc. "(NASDAQ:HQY) This Quarter" was first published by Community Financial News and is the sole property of of Community Financial News.

Friedberg Investment Management holds 2.9% of its portfolio in HFF, Inc. for 209,577 shares. Exane Derivatives bought a new position in shares of HealthEquity during the second quarter valued at about $132,000. FMR LLC now owns 1,248,441 shares of the company's stock worth $50,587,000 after buying an additional 680,671 shares during the period. Alps Advisors Inc. boosted its stake in shares of HealthEquity by 0.3% in the second quarter. The fund acquired 90,200 shares of the company's stock, valued at approximately $3,829,000. Finally, Ameritas Investment Partners Inc. bought a new position in shares of HealthEquity during the first quarter valued at about $158,000. NBW Capital LLC now owns 36,974 shares of the company's stock valued at $1,570,000 after buying an additional 17,098 shares during the last quarter. Nationwide Fund Advisors now owns 236,865 shares of the company's stock valued at $10,055,000 after buying an additional 93,861 shares during the last quarter. Finally, AQR Capital Management LLC purchased a new position in shares of HealthEquity during the fourth quarter worth $293,000. Following the completion of the sale, the director now owns 6,381 shares in the company, valued at approximately $326,962.44. HealthEquity has a 52 week low of $28.39 and a 52 week high of $54.95. The stock decreased 2.82% or $1.34 during the last trading session, reaching $46.14. The company's stock had a trading volume of 579,253 shares. HealthEquity, Inc. The stock's 50-day moving average price is $48.74 and its 200-day moving average price is $46.12. The stock has a market cap of $2.69 billion, a PE ratio of 84.45 and a beta of 1.73. Suntrust Robinson maintained Healthequity Inc (NASDAQ:HQY) on Wednesday, June 8 with "Buy" rating. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The company's revenue for the quarter was up 25.9% on a year-over-year basis. During the same quarter previous year, the firm earned $0.15 earnings per share.

There has been some selling insider activity on HealthEquity, Inc. Healthequity Inc (NASDAQ:HQY) has risen 95.58% since August 10, 2016 and is uptrending. "(HQY)" was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of USA and worldwide trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/12/healthequity-inc-hqy-lifted-to-buy-at-zacks-investment-research-updated-updated-updated.html. The value of the total investment in HealthEquity, Inc. increased from $8,391,000 to $10,552,000 increasing 25.8% for the reporting period. The firm has "Buy" rating by Chardan Capital Markets given on Wednesday, June 7. HealthEquity Inc had 20 analyst reports since August 18, 2015 according to SRatingsIntel. Zacks Investment Research downgraded HealthEquity from a "buy" rating to a "hold" rating in a research note on Friday, August 4th. Chardan Capital reiterated a "buy" rating and issued a $53.00 price objective (up previously from $50.00) on shares of HealthEquity in a research note on Wednesday, March 22nd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. $41.33's average target is -8.40% below currents $45.12 stock price. Also, Director Frank Medici sold 210,906 shares of the company's stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $52.03, for a total value of $10,973,439.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Stephen Neeleman sold 40,000 shares of the stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $51.24, for a total transaction of $27,521,106.48. Glen Harbor Capital Management LLC now owns 43,956 shares of the company's stock valued at $1,866,000 after buying an additional 154 shares during the period. The disclosure for this sale can be found here. Vanguard Group Inc. now owns 4,115,237 shares of the company's stock valued at $174,691,000 after buying an additional 240,136 shares during the period. Institutional investors own 90.35% of the company's stock.